Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON — Improvement in plaque psoriasis itch and severity, including in intertriginous areas, was significant in patients treated with roflumilast, according to a poster presented at the American Academy of Dermatology Annual Meeting. “Roflumilast is a nonsteroid, phosphodiesterase-4 inhibitor, so it has a very benign mechanism of action,” Mark G. Lebwohl, MD, dean for clinical
Routinely ordering mycobacterial cultures for patients with periprosthetic joint infections is not cost-effective and testing is not necessary in most cases, according to a study.
Krishna Komanduri, MD, has been appointed division chief of hematology-oncology at UCSF Health.Komanduri, recognized for his expertise in the fields of cellular immunotherapy and transplantation, also will serve as physician-in-chief of Helen Diller Family Comprehensive Cancer Center and clinical director of UCSF Living Therapeutics Initiative.
Baricitinib reduces structural joint damage progression in rheumatoid arthritis even among patients with who continue to exhibit moderate or high disease activity, according to data published in Annals of the Rheumatic Diseases. “The results presented reveal that baricitinib, with/without de novo [methotrexate (MTX)] or with background MTX, enhances disease-modifying effects by blunting the
DENVER — A leader must first have personal awareness before taking action during a crisis, according to the keynote speaker here at the Anxiety and Depression Association of America annual conference. “This health crisis has been simmering for decades … certainly COVID-19 uncovered a lot of crises in addition to injustices we saw,” Patrice Harris, MD, MA, cofounder and